Endpoints seeks a biopharma breaking news reporter

Endpoints News is seeking a US-based junior biotech and pharma reporter to join our breaking news team, who will work closely with our global editors to help write stories for our morning newsletter.

In this role, you’ll write two to three stories a day and will cover daily news on the biotech and pharma industries. You’ll coordinate closely with our US-based team and our global editors, getting ahead of the American morning to get our coverage out on time.

Stories range from a few hundred words on fast-moving news items like clinical trial results, M&A deals and CEO changes, to longer reporting-driven pieces on business and scientific developments. You’ll react to news and write a lot of copy, and we’re busy enough that there will be ample opportunities for ambitious candidates to hunt scoops and get involved in bigger projects as they learn the beat and grow as a journalist.

You’re the right candidate if you have one to two years of experience covering biotech, pharma or medical science for a trade or specialty publication. You should know what a p-value is and the difference between a biologic and a small molecule, and be ready to expand your skills as a reporter and writer with coaching and support from the team.

This role is part of a group of journalists who report to our deputy editor for newsletters.

To apply, go here.

Chris Roush

Chris Roush was the dean of the School of Communications at Quinnipiac University in Hamden, Connecticut. He was previously Walter E. Hussman Sr. Distinguished Professor in business journalism at UNC-Chapel Hill. He is a former business journalist for Bloomberg News, Businessweek, The Atlanta Journal-Constitution, The Tampa Tribune and the Sarasota Herald-Tribune. He is the author of the leading business reporting textbook "Show me the Money: Writing Business and Economics Stories for Mass Communication" and "Thinking Things Over," a biography of former Wall Street Journal editor Vermont Royster.